Ciprofloxacin-induced torsade de pointes
Authors:
- M. Casey FlanaganMFM. Casey Flanagan
- Eric S. MitchellEMEric S. Mitchell
- Mark C.P. HaigneyMHMark C.P. Haigney
- 1 November 2006
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 113 (2) , 239-241
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Drugs and the QT Interval — Caveat DoctorNew England Journal of Medicine, 2004
- Torsades de pointes associated with fluoroquinolones: Importance of concomitant risk factorsClinical Pharmacology & Therapeutics, 2004
- Gatifloxacin-Associated Corrected QT Interval Prolongation, Torsades de Pointes, and Ventricular Fibrillation in Patients with Known Risk FactorsClinical Infectious Diseases, 2002
- Rates of Torsades de Pointes Associated with Ciprofloxacin, Ofloxacin, Levofloxacin, Gatifloxacin, and MoxifloxacinPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2001